Dyspepsia (cont.)Medical Author:
Jay W. Marks, MD
Jay W. Marks, MDJay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles. Medical Editor:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. In this Article
What is in the future for dyspepsia (indigestion)?The future of dyspepsia will depend on our increasing knowledge of the processes (mechanisms) that cause dyspepsia. Acquiring this knowledge, in turn, depends on research funding. Because of the difficulties in conducting research in dyspepsia, this knowledge will not come quickly. Until we have an understanding of the mechanisms of dyspepsia, newer treatments will be based on our developing a better understanding of the normal control of gastrointestinal function, which is proceeding more rapidly. Specifically, there is intense interest in intestinal neurotransmitters, which are chemicals that the nerves of the intestine use to communicate with each other. The interactions of these neurotransmitters are responsible for adjusting (modulating) the functions of the intestines, such as contraction of muscles and secretion of fluid and mucus. 5-hydroxytriptamine (5-HT or serotonin) is a neurotransmitter that stimulates several different receptors on nerves in the intestine. Examples of experimental drugs for intestinal neurotransmission are sumatriptan (Imitrex) and buspirone (Buspar). These drugs are believed to reduce the responsiveness (sensitivity) of the sensory nerves to what's happening in the intestine by attaching to a particular 5-HT receptor, the 5-HT1 receptor. The 5-HT1 receptor drugs, however, have received only minimal study so far and their role in the treatment of dyspepsia, if any, is unknown. Promotility drugs similar to cisapride, as previously discussed, are being pursued actively. Dyspepsia (Indigestion) At A Glance
REFERENCE: MedscapeToday.com. Functional Dyspepsia. Reviewed by William C. Shiel Jr., MD, FACP, FACR on 4/18/2012 Patient CommentsViewers share their comments
Dyspepsia - Causes
Question: If known, discuss the cause of your dyspepsia.
Dyspepsia - Tests
Question: What tests did you receive that resulted in a diagnosis of dyspepsia?
Dyspepsia - Complications
Question: What have been the complications you have experienced with dyspepsia?
Indigestion - Treatments
Question: What was the treatment for your dyspepsia?
Indigestion - Symptoms
Question: What symptoms did you experience with your indigestion?
|
Get the latest health and medical information delivered direct to your inbox FREE!


